Recently Viewed

News Announcement

Sudarshan Pharma Industries: Announcement under Regulation 30 (LODR)-Diversification / Disinvestment

13-Aug-2026 Follow Value Research Online on Google download pdfDownload PDF Sudarshan Pharma

The Board of Directors at their Meeting held on 12/August/2026 approved the divestment of 2 09 100 equity shares (51.00% of paid up share capital) of Ishwari Healthcare Private Limited. Upon completion of divestment Ishwari Healthcare Private Limited would cease to be a subsidairy of the Company.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.

These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan